Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 1091-1100 Newer>

BusinessWeek April 12, 2004 John Carey	Gene-Based Therapy: Back To The Couch Recent setbacks show (again) that biotech needs more patience and less ballyhoo
BusinessWeek April 12, 2004 Gene G. Marcial	Taking Heart At ATS Medical New management at ATS Medical, a maker of mechanical heart valves, is giving shareholders fresh hope.
CIO April 1, 2004 Malcolm Wheatley	Why Brit Health Project Does Everything Twice Britain's National Health Service in recent months has been awarding contracts for a major IT project: creating a database of electronic patient records that will include every citizen in England.
The Motley Fool April 1, 2004 Charly Travers	Atrix Batting 1.000 Atrix Laboratories' drugs have breezed past the Food and Drug Administration.
ifeminists March 31, 2004 Tony Zizza	GSK Uses Sports Icon as Newest Propaganda Tool Glaxo Smith Kline are masters of deception and using Terry Bradshaw as their newest propaganda tool is just more evidence of their insistence that Paxil be in every American home's medicine cabinet.
Bio-IT World March 17, 2004 Zachary Zimmerman	Testing Times for the FDA The FDA's pharmacogenomic guidance marks the beginning of a long process toward standardized tests.
Fast Company April 2004 Scott Kirsner	Fantastic Voyage Cyberonics' medical implant is the size of a chocolate-chip cookie, and it could be worth $2.8 billion someday. But as this dramatic tale of innovation and entrepreneurship shows, saving lives can be one tough business.
Fast Company April 2004 Christine Canabou	Fast Talk: Life Savers It is the most important industry the world will ever know--keeping people alive. It's a huge undertaking by physicians, researchers, product engineers, and more. We asked some of the best: How do they save lives?
The Motley Fool March 29, 2004 W.D. Crotty	OraSure Not That Sure Its oral-fluid HIV test is a breakthrough, but the stock isn't cheap.
The Motley Fool March 29, 2004 Jeff Hwang	Amgen Deals Again Two years after acquiring Immunex, Amgen takes Tularik.
<Older 1091-1100 Newer> Return to current articles.